Still eating too much on Wegovy? Here's what's actually going on

Step 1: Understand what Wegovy is actually doing at each dose stage

Semaglutide works by activating GLP-1 receptors involved in appetite regulation and gastric emptying. In plain terms, it slows how quickly your stomach empties, raises feelings of fullness after eating, and reduces the brain's drive to seek food. The operative word is reduces, not eliminates. According to the NHS medicines page for semaglutide, the standard dose pathway runs from 0.25mg up to 2.4mg across roughly 16 to 20 weeks of gradual increases.

At the lower starter doses, the pharmacological effect on appetite is modest. That's by design: the slow escalation exists primarily so your gut adjusts and nausea stays manageable, not because appetite suppression begins in earnest at week one. Many people eating too much during the first few months of Wegovy are simply at a dose where full suppression hasn't arrived yet. Patience with the process is legitimate clinical advice, not a workaround.

It's also worth knowing that the STEP 1 trial, published in the New England Journal of Medicine, reported an average weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, alongside reduced-calorie diet and activity. Those results come from the full treatment period, not from the early titration phase.

Step 2: Identify whether the overeating is physical, habitual or emotional

This distinction matters more than most people expect. Wegovy blunts physiological hunger, the stomach rumbling, the lightheadedness, the irritability that comes from low blood sugar. What it does not do is rewire learnt behaviour. If you've spent years eating at a certain time because that's what you do, or finishing everything on your plate out of habit, or reaching for food when you're stressed, those patterns don't automatically dissolve with a weekly injection.

Thinking about how your approach to food needs to shift while you're on Wegovy more broadly can help here. Ask yourself: am I actually hungry, or is this the time I always eat? Is the portion size driven by appetite, or by what's on the plate? That moment of reflection is brief, but it's doing something the medicine itself can't.

Emotional eating is particularly persistent. Semaglutide has no direct effect on stress responses, anxiety or low mood. If food has long served as a coping mechanism, that function doesn't vanish. Some people find that as physical hunger recedes, the emotional component becomes more visible rather than less.

Step 3: Adjust the practical eating environment to support the medicine

Several practical behaviours actively work against Wegovy's mechanism. Eating quickly is probably the biggest one. Because semaglutide slows gastric emptying and enhances satiety signalling, those signals still take time to reach the brain, roughly 15 to 20 minutes from the start of a meal. Eating faster than that means you can consume far more than you need before fullness registers. Slowing down isn't just advice from a 1970s diet book; it has a physiological rationale on this treatment.

Skipping meals creates a different problem. Arriving at a meal very hungry after a long gap can produce an appetite spike that temporarily overrides suppression, particularly early in treatment. Spacing meals more evenly through the day tends to keep the drug's effect steadier. Protein-rich foods and fibre also slow gastric emptying further and extend satiety; exploring which foods work best alongside Wegovy gives you a practical food-first framework to build on.

On the sugar and refined-carbohydrate side, it's also worth reading about how excess sugar intake specifically interacts with treatment, highly palatable, fast-digesting foods can partly circumvent satiety signals even on a GLP-1 medicine.

Step 4: Know when to raise it with your prescriber

Persistent overeating well into maintenance dose (especially if weight loss has stalled or plateaued) is a clinical conversation, not a personal failing. Your prescriber can assess whether the dose is right, whether a structured eating plan alongside treatment would help, or whether other factors are at play.

The NHS England guidance on weight management injections is clear that medicines work best alongside dietary support and behaviour change, Wegovy is not intended to replace those elements. If you're on a private prescription and haven't discussed eating patterns with a clinician recently, that's the right next step. You can also check what happens at the other end of the spectrum (some people find appetite suppression becomes too strong) to get a sense of the full range of responses prescribers see.

If you haven't yet started treatment and want to understand whether Wegovy is right for you, our prescribers review every consultation personally. You can start your free consultation here and get a same-day clinical assessment.